SAGE
Sage Therapeutics
SAGE
SAGE
Delisted
SAGE was delisted on the 30th of July, 2025.
247 hedge funds and large institutions have $4.65B invested in Sage Therapeutics in 2020 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 74 increasing their positions, 85 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.12% more ownership
Funds ownership: 103.25% → 103.37% (+0.12%)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
13% less repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 85
Holders
247
Holding in Top 10
7
Calls
$54.8M
Puts
$46.6M
Top Buyers
| 1 | +$350M | |
| 2 | +$38.2M | |
| 3 | +$38.1M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$31.1M |
| 5 |
MWNA
Marshall Wace North America
New York
|
+$25.9M |
Top Sellers
| 1 | -$131M | |
| 2 | -$80.1M | |
| 3 | -$43.3M | |
| 4 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$30.5M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$29.7M |